The Longevity Podcast: Optimizing HealthSpan & MindSpan

Dung Trinh
  • 5.0 (1)
  • Health & Fitness
  • Updated Weekly

Welcome to a new era of conversation—where artificial intelligence explores what it means to live longer and better. Created and guided by Dr. Trinh, The Longevity Podcast uses AI hosts to bring scientific discovery, health innovation, and human wisdom together. Through AI-driven discussions inspired by real research and medical insight, each episode reveals practical tools for optimizing your healthspan and mindspan—rooted in science, shaped by compassion. Mind. Body. Spirit.  Powered by Science, Guided by Humanity.

  1. Aug 17

    AFib And Dementia Risk

    Send us Fan Mail This podcast is created by Ai for educational and entertainment purposes only and does not constitute professional medical or health advice. Please talk to your healthcare team for medical advice.  Never miss an episode—subscribe on your favorite podcast app!

  2. Aug 10

    How Cardiovascular Risk Quietly Speeds Cognitive Decline

    Send us Fan Mail Your brain’s future might be readable from your cardiovascular risk score right now. We walk through a dense but deeply practical research paper from the Journal of Prevention of Alzheimer’s Disease that links 10-year ASCVD risk to the pace of cognitive decline, without needing a brain scan to spot the warning signs. The big idea is simple: cognitive preservation is not just a neuroscience problem. It is a vascular health problem, and the “plumbing” shows up in numbers you can measure today. We trace the study’s real-world setting in Project Frontier, following adults in rural West Texas where access to specialty care is harder and unmanaged chronic conditions can quietly compound. Then we unpack how the AHA PREVENT equations build an ASCVD risk score using systolic blood pressure, cholesterol, diabetes status, smoking, and kidney function (eGFR). That score is usually treated as a heart attack and stroke forecast, but here it acts as a proxy for cumulative microvascular stress that also threatens the brain’s smallest vessels. On the cognition side, we break down the RBANS battery and supporting tests like Trail Making, verbal fluency, and clock drawing. The key pattern is unsettling and specific: higher cardiovascular disease risk aligns with faster drops in attention and delayed memory, while some language and visuospatial skills look more protected in the short window. We also explore why long-term baseline risk matters more than one-off spikes, how “practice effects” reveal neuroplasticity, and why education and income can create cognitive reserve even when vascular damage is present. If you care about memory, focus, and staying sharp, this is a roadmap to what to monitor and what to change. Subscribe, share this with someone who thinks brain health is only about the brain, and leave a review with your biggest takeaway. This podcast is created by Ai for educational and entertainment purposes only and does not constitute professional medical or health advice. Please talk to your healthcare team for medical advice.  Never miss an episode—subscribe on your favorite podcast app!

  3. Aug 7

    When Your Memory Blinks

    Send us Fan Mail You know that moment when you open the refrigerator and forget what you came for, or you recognize an actor’s face but their name is gone? Most of us laugh it off, but the fear behind it is real: what if it’s not stress or sleep, but the earliest sign of Alzheimer’s disease? We break down a landmark 2026 study that asks a surprisingly uncomfortable question: who is the more reliable narrator of your cognitive health, you or the person closest to you? Using the Everyday Cognition (ECog) questionnaire across large longitudinal cohorts, researchers compare self-reports with “study partner” reports from spouses and adult children, then link both to hard biology like amyloid beta and tau. Along the way we explain why quick screening tools like the MMSE can miss subtle declines in planning, language, navigation, and multitasking, and why a single baseline snapshot can be misleading when Alzheimer’s pathology can build silently for years. The most important twist is about insight. As Alzheimer’s progresses, many people begin to lose accurate self-awareness due to anosognosia, a neurological inability to perceive impairment that is not simple denial. That’s why the partner’s year-over-year observations can become the loudest early alarm, and why a one-year increase in partner-rated ECog can signal sharply higher near-term risk when amyloid is present. We also zoom out to the big implication: what happens to early detection for people who live alone, and could AI, wearables, or smart homes someday act as a “digital study partner”? If this made you rethink memory concerns and caregiver observations, subscribe, share this with someone supporting an aging loved one, and leave a review with the biggest question you’re still sitting with. This podcast is created by Ai for educational and entertainment purposes only and does not constitute professional medical or health advice. Please talk to your healthcare team for medical advice.  Never miss an episode—subscribe on your favorite podcast app!

  4. Aug 6

    Blood Based Biomarkers Predicting Memory Loss

    Send us Fan Mail Imagine learning that your brain is on a specific trajectory toward memory loss and you find out from a routine blood draw, not a spinal tap, not a hard-to-access PET scan. That future is arriving fast, and it’s creating a new challenge: we don’t have one “Alzheimer’s blood test” anymore. We have a growing menu of brain biomarkers, each reporting on a different kind of cellular crisis, and the only way to use them well is to match the marker to the underlying biology. We walk through four of the biggest names in blood-based dementia diagnostics and brain health monitoring: p-tau217, p-tau181, NFL (neurofilament light chain), and GFAP. You’ll learn what each protein normally does, what it means when it shows up in plasma, and how ultrasensitive Simoa technology can measure these signals at almost unimaginable concentrations. Then we dig into a rigorous 2026 study that compares two very different cohorts, a South Korean memory clinic group and the North American ADNI research cohort, to test whether these biomarkers hold up across demographics, education levels, and disease stages. The headline finding is a true plot twist: amyloid status flips the winners. In amyloid-positive people, p-tau217 emerges as the strongest predictor of cognitive decline, while GFAP can be a dominant signal for brain atrophy in symptomatic patients. In amyloid-negative people, NFL becomes the most reliable indicator of neurodegeneration and overall cognitive worsening, pointing to non-Alzheimer’s causes where general axonal injury is the key story. If you care about early Alzheimer’s detection, precision neurology, or the future of dementia screening, this is the framework to know. Subscribe, share this with someone navigating memory concerns, and leave a review with the biomarker question you want answered next. This podcast is created by Ai for educational and entertainment purposes only and does not constitute professional medical or health advice. Please talk to your healthcare team for medical advice.  Never miss an episode—subscribe on your favorite podcast app!

  5. Aug 6

    How Europe Decides Who Gets An Alzheimer’s Breakthrough Drug

    Send us Fan Mail This podcast is created by Ai for educational and entertainment purposes only and does not constitute professional medical or health advice. Please talk to your healthcare team for medical advice.  Never miss an episode—subscribe on your favorite podcast app!

  6. Aug 6

    The New Alzheimer’s Timeline And The Tests That Catch It Early

    Send us Fan Mail You can “pass” a memory test and still reveal something chilling: your brain can confidently invent a word that was never said. We start there because that tiny intrusion error, caught by the right kind of neuropsychological scoring, may be one of the earliest objective signals of Alzheimer’s disease long before you lose your keys or miss an appointment. We unpack a 2026 narrative review that argues Alzheimer’s isn’t a sudden drop from healthy to sick, but a decades-long biological process. The centerpiece is Objectively Defined Subtle Cognitive Decline (ObjSCD), a new stage between cognitively normal aging and mild cognitive impairment. We explain the actuarial criteria behind it, why “process scores” matter as much as total scores on tests like the Ray Auditory Verbal Learning Test, and how longitudinal ADNI data links these subtle patterns to higher rates of progression to MCI and dementia. We also dig into the compounding role of type 2 diabetes, showing how metabolic and inflammatory stress can accelerate decline. Then we go under the hood with the ATN framework and modern biomarkers: amyloid PET findings, tau biology, early structural changes like entorhinal cortex thinning, white matter damage, and the surprising spike in cerebral blood flow that suggests the brain is compensating before it collapses. We close with what could make early detection scalable: blood-based biomarkers such as p-tau217 and NfL paired with short digital cognitive screens, plus the hard equity question of building algorithms on narrow datasets. If a simple blood draw and a 10-minute iPad test could predict Alzheimer’s risk decades early, would you want to know? Subscribe, share this with someone who thinks about brain health, and leave a review with your answer. This podcast is created by Ai for educational and entertainment purposes only and does not constitute professional medical or health advice. Please talk to your healthcare team for medical advice.  Never miss an episode—subscribe on your favorite podcast app!

  7. Aug 6

    When The Brain’s Sanitation Team Goes Rogue

    Send us Fan Mail Alzheimer’s has been treated like a neuron problem for decades, but what if the real lever sits in the brain’s support system, quietly failing long before symptoms show up? We dig into a 2026 Journal of Prevention of Alzheimer’s Disease paper that uses a massive transcriptomic dragnet across multiple human datasets to spotlight one surprising hub: CD44, a receptor best known outside the brain, now showing up as a major signal across vulnerable Alzheimer’s regions. We walk through why amyloid plaque clearing therapies can slow decline yet still come with modest benefit and serious tradeoffs like ARIA, frequent infusions, and intensive monitoring. Then we follow the evidence trail: region-by-region gene expression analysis, network hub logic, convergent functional genomic ranking, and the clinical “timeline paradox” where CD44 spikes in asymptomatic Alzheimer’s but does not neatly track with later cognitive severity. That pattern pushes us to treat CD44 as an early priming event, not a late-stage scar. The biggest shift comes from single-nucleus RNA sequencing. CD44 is not coming from dying neurons. It is concentrated in astrocytes, particularly a neurotoxic reactive subpopulation tied to impaired autophagy, the brain’s protein waste recycling system. Using cell-to-cell communication modeling, the paper implicates microglial osteopontin (SPP1) signaling into astrocyte CD44, potentially jamming intracellular transport and stalling autophagic “garbage trucks.” We also cover the Petri-dish validation where CD44 knockdown restores autophagic flux markers and CD44 overexpression makes them worse. If you care about Alzheimer’s disease research, astrocytes, microglia, autophagy, and next-generation therapeutic targets beyond amyloid, this is the map. Subscribe, share this with a friend who follows neuroscience, and leave a review with your take: should the next wave of trials prioritize restoring brain cleanup over clearing plaques? This podcast is created by Ai for educational and entertainment purposes only and does not constitute professional medical or health advice. Please talk to your healthcare team for medical advice.  Never miss an episode—subscribe on your favorite podcast app!

  8. Aug 4

    Fascia And The Hidden Roots Of Mood

    Send us Fan Mail Your shoulders creep toward your ears during a brutal month. Your chest tightens during panic. Your body feels heavy during depression. We usually call those downstream symptoms, but the research we’re unpacking argues for something far more disruptive: fascia may help generate the very emotional states we blame on the brain alone. We walk through a major 2026 review that reframes fascia as a continuous, body-wide sensory network rather than inert “wrapping paper.” From superficial fascia under the skin to deep fascia that transmits force, visceral fascia that lets organs glide, and parietal fascia that shapes the felt boundaries of the body, the anatomy sets the stage for the mental health link. Then we zoom into neurology: roughly 250 million nerve endings feeding interoception and proprioception, creating the quiet background signal that can register as safety, grounding, and mood. From there, we trace the mechanism from chronic stress, trauma, and insomnia to sympathetic overactivity, ischemia, inflammation, TGF beta 1 signaling, and fibroblasts shifting into contractile myofibroblasts. Add hyaluronic acid densification and you get a stiff, sticky matrix that can distort afferent input into “interoceptive noise.” We connect that noise to anxiety, depression, altered pain perception, and findings from TMS studies that suggest reduced cortical inhibition. Finally, we get practical: mechanotransduction through sustained stretching, myofascial release, yoga, and somatic meditation, plus the role of diaphragmatic breathing and the vagus nerve in restoring parasympathetic balance. If you’ve ever felt like your body won’t let your mind calm down, this deep dive is for you. Subscribe, share this with someone who lives in tension, and leave a review with one question you want answered next. This podcast is created by Ai for educational and entertainment purposes only and does not constitute professional medical or health advice. Please talk to your healthcare team for medical advice.  Never miss an episode—subscribe on your favorite podcast app!

See All (397)

About

Welcome to a new era of conversation—where artificial intelligence explores what it means to live longer and better. Created and guided by Dr. Trinh, The Longevity Podcast uses AI hosts to bring scientific discovery, health innovation, and human wisdom together. Through AI-driven discussions inspired by real research and medical insight, each episode reveals practical tools for optimizing your healthspan and mindspan—rooted in science, shaped by compassion. Mind. Body. Spirit.  Powered by Science, Guided by Humanity.

Information